Invention Grant
- Patent Title: Methods of treating chronic inflammatory diseases
-
Application No.: US14966679Application Date: 2015-12-11
-
Publication No.: US10213482B2Publication Date: 2019-02-26
- Inventor: Sylviane Muller , Robert H. Zimmer , Jean-Paul Briand
- Applicant: Centre National de la Recherche Scientifique , ImmuPharma France SA
- Applicant Address: FR Mulhouse FR Paris
- Assignee: ImmuPharma France SA,Centre National De La Recherche Scientifique
- Current Assignee: ImmuPharma France SA,Centre National De La Recherche Scientifique
- Current Assignee Address: FR Mulhouse FR Paris
- Agency: Cantor Colburn LLP
- Agent Bryan D. Zerhusen, Esq.
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/47
Abstract:
The present invention relates to a peptide, or a salt thereof, comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY, comprising one or more post-translational modifications, for the treatment, prevention or amelioration of a hyper autophagy-related autoimmune disease or disorder.
Public/Granted literature
- US20160166636A1 MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES Public/Granted day:2016-06-16
Information query
IPC分类:
